Mouse Models to Study Antiobesogenic Effects of Carotenoids.


Journal

Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969

Informations de publication

Date de publication:
2020
Historique:
entrez: 21 11 2019
pubmed: 21 11 2019
medline: 5 1 2021
Statut: ppublish

Résumé

Carotenoids entail a vast potential to tackle health problems including obesity and some of its comorbidities. The use of animal models remains necessary, particularly at early stages of research (preclinical) and for advancing in mechanistic aspects of carotenoid action. No single animal model completely mimics human absorption and metabolism of carotenoids, and the best model must be chosen considering the specific application, characteristics of the individual models, and funding and facilities available. Here, we propose three protocols in mice to investigate the potential of a given carotenoid, carotenoid mixture, or carotenoid-rich extract to (a) counteract the development of obesity and prevent the metabolic alterations caused by feeding mice a moderate high-fat diet; (b) improve the metabolic profile of obese animals with metabolic alterations caused by chronic high-fat diet feeding; and (c) act as coadjuvants in weight loss strategies (reversion to a low fat diet) applied to diet-induced obese animals.

Identifiants

pubmed: 31745938
doi: 10.1007/978-1-4939-9952-1_30
doi:

Substances chimiques

Anti-Obesity Agents 0
Biomarkers 0
Blood Glucose 0
Carotenoids 36-88-4

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

403-417

Auteurs

Joan Ribot (J)

Grup de Recerca Nutrigenòmica i Obesitat, Laboratori de Biologia Molecular, Nutrició i Biotecnologia (LBNB) of the Universitat de les Illes Balears, CIBER de Fisiopatología de la Obesidad y Nutrición (CIBERobn) and Institut d'Investigació Sanitària Illes Balears (IdISBa), Palma de Mallorca, Spain. joan.ribot@uib.es.

Bojan Stojnic (B)

Grup de Recerca Nutrigenòmica i Obesitat, Laboratori de Biologia Molecular, Nutrició i Biotecnologia (LBNB) of the Universitat de les Illes Balears, CIBER de Fisiopatología de la Obesidad y Nutrición (CIBERobn) and Institut d'Investigació Sanitària Illes Balears (IdISBa), Palma de Mallorca, Spain.

Andreu Palou (A)

Grup de Recerca Nutrigenòmica i Obesitat, Laboratori de Biologia Molecular, Nutrició i Biotecnologia (LBNB) of the Universitat de les Illes Balears, CIBER de Fisiopatología de la Obesidad y Nutrición (CIBERobn) and Institut d'Investigació Sanitària Illes Balears (IdISBa), Palma de Mallorca, Spain.

M Luisa Bonet (ML)

Grup de Recerca Nutrigenòmica i Obesitat, Laboratori de Biologia Molecular, Nutrició i Biotecnologia (LBNB) of the Universitat de les Illes Balears, CIBER de Fisiopatología de la Obesidad y Nutrición (CIBERobn) and Institut d'Investigació Sanitària Illes Balears (IdISBa), Palma de Mallorca, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH